Janitri

Dr. Sarita Patel, founder of Janitri, brings 20+ years of medical expertise in women's health and reproductive science. Her motivation: developing countries lack affordable maternal healthcare technology. Janitri was created as medical device platform providing tools for better maternal health management, particularly in resource-limited settings.

Janitri manufactures affordable, portable maternal health monitoring devices and telemedicine platform. Products include devices for monitoring pregnancy health, postpartum care tracking, and newborn health assessment. Platform enables remote monitoring, connects pregnant women with healthcare providers, and provides health education. Target: pregnant women in tier-2/tier-3 cities and rural India with limited healthcare access.

Amount: Rs 2 crore | Equity: 5% | Valuation: Rs 40 crore

Dr. Patel presented maternal health crisis: India has highest maternal mortality rates globally despite improvements. Janitri provides technology solution for monitoring and early intervention. Metrics: 100,000+ women using platform, partnerships with 500+ healthcare providers, 50+ district hospital collaborations, strong clinical validation.

Namita Thapar immediately connected with healthcare mission and women's health focus. Her pharmaceutical industry background gave her credibility to evaluate medical claims. She appreciated clinical rigor and healthcare provider partnerships. Anupam Mittal was supportive but raised regulatory concerns specific to medical devices.

Namita offered Rs 2 crore for 8% equity. Dr. Patel countered Rs 2 crore for 5% citing clinical partnerships and regulatory approvals. Namita accepted 5% valuing founder's medical expertise. Deal included introductions to hospital networks and potential distribution partnerships.

Deal Secured: YES | Investment: Rs 2 crore | Equity: 5% | Shark: Namita Thapar